Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_assertion type Assertion NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_head.
- NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_provenance.
- NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_assertion evidence source_evidence_literature NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_provenance.
- NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_assertion SIO_000772 23603816 NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_provenance.
- NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_assertion wasDerivedFrom befree-20150227 NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_provenance.
- NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_assertion wasGeneratedBy ECO_0000203 NP645860.RAnpaqVOPQYEF76zUroFJhi2Jyk46uadiQBhho9i1FFiI130_provenance.